Our study performed a pan-cancer analysis to evaluate expression levels and genetic alterations of NCAPG2 and found that NCAPG2 were elevated in tumor samples compared to normal samples across various types of cancer, indicating that NCAPG2 may serve as a critical oncogene for cancer development and progression. This evidence concerns the gene NCAPG2 and cancer.